September is observed as “Gynecological Cancer Awareness Month” in the United States. Sponsored by the Foundation for Women’s Cancer (FWC), the campaign brings to light information regarding different gynecologic cancers, and how they affect women across the globe. Reports from the American Association for Cancer Research show that 16,900,000 gynecologic cancer survivors are living in the U.S. According to the Centers for Disease Control, approximately 89,000 women are diagnosed with gynecological cancers every year. Gynecological cancer refers to a form of cancer that affects the female reproductive system – including the cervix, ovaries, fallopian tubes, uterus, vulva, and vagina. Every woman is at risk of this cancer, but these risks increase with age. However, the risks of these cancers can be prevented if the signs and symptoms are recognized early before the disease reaches a critical stage. Treatment options depend on several factors such as the stage and type of cancer and other health problems. Gynecologic oncologists and other specialists administering different treatment modalities should have up-to-date knowledge about the latest guidelines or practices for medical billing and coding. For correct clinical documentation of this disorder, physicians can benefit from the services of medical billing outsourcing companies.
The 2021 campaign is a perfect platform to share knowledge about gynecologic cancer symptoms, risk factors, prevention and early detection. Family history, obesity, age, genetics and HPV are important risk factors for gynecologic cancer. Other risk factors are smoking, obesity, a weakened immune system, diabetes, history of sexual activity and long-term use of oral contraceptives, among others.
Each gynecologic cancer is unique, with different signs and symptoms, risk factors and prevention strategies. Symptoms include – pelvic pain or pressure that doesn’t go away, feeling too full (even when eating just a little), unusual vaginal bleeding, longer or heavier periods than usual, unusual discharge from the vagina, pain during sex, lower back pain and pain or swelling in the legs. Treatment for gynecologic cancers involves a combination of one or more treatment modalities. Treatment for this condition depends on the kind of cancer and how far it has spread. Treatment options include surgery, chemotherapy, and radiation. Patients often get more than one kind of treatment.
Gynecology medical billing and coding can be challenging. When documenting gynecologic cancers, gynecology oncologists or other specialists must include the associated symptoms, diagnosis, screening tests and other treatment procedures performed using the correct medical codes. Billing and coding services provided by reputable medical coding companies can help physicians use the right medical codes for their medical billing purposes. ICD-10 diagnosis codes for gynecologic cancers –
- C51 Malignant neoplasm of vulva
- C51.0 Malignant neoplasm of labium majus
- C51.1 Malignant neoplasm of labium minus
- C51.2 Malignant neoplasm of clitoris
- C51.8 Malignant neoplasm of overlapping sites of vulva
- C51.9 Malignant neoplasm of vulva, unspecified
- C52 Malignant neoplasm of vagina
- C53 Malignant neoplasm of cervix uteri
- C53.0 Malignant neoplasm of endocervix
- C53.1 Malignant neoplasm of exocervix
- C53.8 Malignant neoplasm of overlapping sites of cervix uteri
- C53.9 Malignant neoplasm of cervix uteri, unspecified
- C54 Malignant neoplasm of corpus uteri
- C54.0 Malignant neoplasm of isthmus uteri
- C54.1 Malignant neoplasm of endometrium
- C54.2 Malignant neoplasm of myometrium
- C54.3 Malignant neoplasm of fundus uteri
- C54.8 Malignant neoplasm of overlapping sites of corpus uteri
- C54.9 Malignant neoplasm of corpus uteri, unspecified
- C55 Malignant neoplasm of uterus, part unspecified
- C56 Malignant neoplasm of ovary
- C56.1 Malignant neoplasm of right ovary
- C56.2 Malignant neoplasm of left ovary
- C56.9 Malignant neoplasm of unspecified ovary
- C57 Malignant neoplasm of other and unspecified female genital organs
- C57.0 Malignant neoplasm of fallopian tube
- C57.1 Malignant neoplasm of broad ligament
- C57.2 Malignant neoplasm of round ligament
- C57.3 Malignant neoplasm of parametrium
- C57.4 Malignant neoplasm of uterine adnexa, unspecified
- C57.7 Malignant neoplasm of other specified female genital organs
- C57.8 Malignant neoplasm of overlapping sites of female genital organs
- C57.9 Malignant neoplasm of female genital organ, unspecified
- C58 Malignant neoplasm of placenta
The Gynecological Cancer Awareness Month was first introduced in 1999 by the Foundation for Women’s Cancer with an objective to highlight risk factors, symptoms and early detection and prevention strategies. The basic purpose behind the month was to spread awareness and encourage research to find a cure for this health condition.
As part of the awareness campaign, the National Foundation for Women’s Cancer hosts a wide variety of programs. These include – regular screenings, creating banners and posters to encourage cancer screenings, distributing monthly newsletters and handouts to patients/students, hosting community events (such as walks/runs, education and fundraising events), wearing teal ribbons or wrist bands, giving presentations to local groups/organizations, and sharing information about these types of cancer on various social media platforms such as Facebook, Twitter and others.
Be part of 2021 Gynecological Cancer Awareness Month observance! Educate women about the importance of early diagnosis and screening to prevent these conditions in the long run.